News
FDA grants breakthrough device designation for Injeq IQ-Tip® smart needle
Injeq is happy to announce that Injeq IQ-Tip device with its indications for use meet the criteria and have been […]
Read more »
Breakthrough Device designation granted by FDA
Injeq IQ-Tip system has been granted the Breakthrough Device designation by FDA! The FDA’s Breakthrough Devices Program is designed to […]
Read more »
Injeq grows – new distributor in Hong Kong
Injeq visited Hong Kong in May and met with local hospital management there. The interest towards Injeq IQ-Tip® system convinced […]
Read more »
Large multicenter trial of pediatric hemato-oncology patients sponsored by Injeq
A clinical investigation conducted in all five Finnish university hospitals and sponsored by Injeq has begun in May. A peer-reviewed […]
Read more »
Two more weeks to go!
There are two weeks left in Injeq’s share issue. Read the promising news and invest: Funding: Injeq Oyj (invesdor.com) […]
Read more »
Injeq IQ-Tip®: Benefits for healthcare and society
Post-dural puncturel headache after lumbar puncture is a difficult post-procedure complication caused by cerebrospinal fluid seeping through the lumbar puncture […]
Read more »
Opportunities for IQ-Tip in research
Sales of Injeq IQ-TipR equipment started at the end of 2021, when Injeq received the CE marking for its products. […]
Read more »
Share issue open! Injeq improves patient safety with a smart needle
Injeq Oyj is a Finnish MedTech company, that offers unique smart needles for demanding patient injections, such as lumbar punctures. […]
Read more »
Tiedote
Injeq on yhdessä Invesdorin kanssa järjestellyt osakeantia, joka käynnistyy ns. ”hiljaisella kierroksella”, jolloin nykyiset omistajat pääsevät merkitsemään osakkeita ensin, jonka […]
Read more »
Injeq’s distributor network is expanding outside Europe
Injeq Plc is proud to introduce Mareen Group, the new distributor of Injeq in the Kuwaiti market. Mareen group, founded […]
Read more »